Draisma G - Search Results

1

Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.

Rijnsburger AJ, van Oortmarssen GJ, Boer R, Draisma G, To T, Miller AB, de Koning HJ. Rijnsburger AJ, et al. Among authors: draisma g. Int J Cancer. 2004 Jul 10;110(5):756-62. doi: 10.1002/ijc.20143. Int J Cancer. 2004. PMID: 15146566 Clinical Trial.

2

MISCAN: estimating lead-time and over-detection by simulation.

Draisma G, De Koning HJ. Draisma G, et al. BJU Int. 2003 Dec;92 Suppl 2:106-11. doi: 10.1111/j.1464-410x.2003.4409x.x. BJU Int. 2003. PMID: 14983966 Clinical Trial.

3

Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.

Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ. Vervoort MM, et al. Among authors: draisma g. Br J Cancer. 2004 Jul 19;91(2):242-7. doi: 10.1038/sj.bjc.6601969. Br J Cancer. 2004. PMID: 15213715 Free PMC article.

4

Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands.

Groenewoud JH, Otten JD, Fracheboud J, Draisma G, van Ineveld BM, Holland R, Verbeek AL, de Koning HJ; NETB. Groenewoud JH, et al. Among authors: draisma g. Breast Cancer Res Treat. 2007 Apr;102(2):211-8. doi: 10.1007/s10549-006-9319-4. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004116

5

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.

Heijnsdijk EA, der Kinderen A, Wever EM, Draisma G, Roobol MJ, de Koning HJ. Heijnsdijk EA, et al. Among authors: draisma g. Br J Cancer. 2009 Dec 1;101(11):1833-8. doi: 10.1038/sj.bjc.6605422. Epub 2009 Nov 10. Br J Cancer. 2009. PMID: 19904272 Free PMC article.

6

Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths.

de Gelder R, Draisma G, Heijnsdijk EA, de Koning HJ. de Gelder R, et al. Among authors: draisma g. Br J Cancer. 2011 Mar 29;104(7):1214-20. doi: 10.1038/bjc.2011.67. Epub 2011 Mar 1. Br J Cancer. 2011. PMID: 21364575 Free PMC article.

7

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals.

van Ravesteyn NT, Heijnsdijk EA, Draisma G, de Koning HJ. van Ravesteyn NT, et al. Among authors: draisma g. Br J Cancer. 2011 Sep 27;105(7):1082-8. doi: 10.1038/bjc.2011.300. Epub 2011 Aug 23. Br J Cancer. 2011. PMID: 21863031 Free PMC article.

8

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ. Draisma G, et al. J Natl Cancer Inst. 2003 Jun 18;95(12):868-78. doi: 10.1093/jnci/95.12.868. J Natl Cancer Inst. 2003. PMID: 12813170 Free article. Clinical Trial.

9

Seventy-five years is an appropriate upper age limit for population-based mammography screening.

Fracheboud J, Groenewoud JH, Boer R, Draisma G, de Bruijn AE, Verbeek AL, de Koning HJ. Fracheboud J, et al. Among authors: draisma g. Int J Cancer. 2006 Apr 15;118(8):2020-5. doi: 10.1002/ijc.21560. Int J Cancer. 2006. PMID: 16287064

10

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.

de Koning HJ, Draisma G, Fracheboud J, de Bruijn A. de Koning HJ, et al. Among authors: draisma g. Breast Cancer Res. 2006;8(1):202. doi: 10.1186/bcr1369. Epub 2005 Dec 21. Breast Cancer Res. 2006. PMID: 16524452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters